http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b97faf72c0481442cb3fc774d0c6897
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Roylance |
| name | Rebecca Roylance |
| given-name | Rebecca |
| organization-name | Barts Cancer Institute CR UK Centre of Excellence, Queen Mary University of London, Charterhouse Square, London, United Kingdom Molecular and Population Genetics Laboratory, Imperial Cancer Research Fund University College London Hospitals NHS Foundation Trust, 235 Euston Rd., London NW1 2BU, UK Cancer Division University College London Hospitals NHS Foundation Trust London UK; UCL Cancer Institute London UK University College Hospitals, NHS Foundation Trust and UCLH Biomedical Research Centre, London, UK. 4Department of Oncology, UCLH Foundation Trust, London, United Kingdom. Authors' Affiliations: 1Cancer Research UK, London Research Institute; 2Bart's and The London School of Medicine and Dentistry, Institute of Cancer, London, United Kingdom; 3University of Applied Sciences, Remagen, Germany; 4The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford; 5Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom; 6Brigham and Women's Hospital, 7Department of Cancer Biology, Dana-Farber Cancer Institute, 8Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts; 9Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark; and 10Department of Medicine, Breast and Drug Development Units, Royal Marsden Hospital, Sutton, United Kingdom; Authors' Affiliations: 1Cancer Research UK, London Research Institute; 2Bart's and The London School of Medicine and Dentistry, Institute of Cancer, London, United Kingdom; 3University of Applied Sciences, Remagen, Germany; 4The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford; 5Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom; 6Brigham and Women's Hospital, 7Department of Cancer Biology, Dana-Farber Cancer Institute, 8Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts; 9Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark; and 10Department of Medicine, Breast and Drug Development Units, Royal Marsden Hospital, Sutton, United Kingdom Authors' Affiliations: 1Barts Cancer Institute—a Cancer Research UK Center of Excellence, John Vane Science Center, Queen Mary University of London; 2Department of Medicine, Imperial College, Charing Cross Campus; 3St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London; 4Wellcome Trust Center for Human Genetics, Oxford; 5Cancer Research UK Cambridge Research Institute, Li Ka Shing Center; 6Hutchison/MRC Research Center, University of Cambridge, Medical Research Council Cancer Unit; 7Pharmacometrics Ltd., Cambridge; 8Dundee Cancer Center, University of Dundee, Ninewells Hospital, Dundee, United Kingdom; 9Laboratory of Cancer Genetics and Translational Oncology, S Croce General Hospital, Cuneo, Italy; 10Department of Structural Biology, Medical University of Lodz, Lodz, Poland; 11Polaris Group, San Diego, California; 12Department of Pathology, Chi-Mei Medical Center; 13Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan; and 14National Institute; Authors' Affiliations: 1Barts Cancer Institute—a Cancer Research UK Center of Excellence, John Vane Science Center, Queen Mary University of London; 2Department of Medicine, Imperial College, Charing Cross Campus; 3St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London; 4Wellcome Trust Center for Human Genetics, Oxford; 5Cancer Research UK Cambridge Research Institute, Li Ka Shing Center; 6Hutchison/MRC Research Center, University of Cambridge, Medical Research Council Cancer Unit; 7Pharmacometrics Ltd., Cambridge; 8Dundee Cancer Center, University of Dundee, Ninewells Hospital, Dundee, United Kingdom; 9Laboratory of Cancer Genetics and Translational Oncology, S Croce General Hospital, Cuneo, Italy; 10Department of Structural Biology, Medical University of Lodz, Lodz, Poland; 11Polaris Group, San Diego, California; 12Department of Pathology, Chi-Mei Medical Center; 13Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan; and 14National Institute NIHR Biomedical Research Centre UCLH/UCL, and Breast Unit, University College London Hospital, London, United Kingdom University College London Hospitals NHS Foundation Trust, London, United Kingdom |
Incoming Links
Total number of triples: 67.